D-1083-2023 Class III Terminated
FDA drug recall D-1083-2023 was initiated by B. Braun Medical Inc. on Aug 2, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed. The recall status is terminated (terminated Jul 7, 2025). Affected quantity: 43,812 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 16, 2023
- Initiation Date
- Aug 2, 2023
- Termination Date
- Jul 7, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,812 bags
Product description
0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00
Reason for recall
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
Distribution pattern
United States
Code information
Lot #: 0061852531, Exp 2/28/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1083-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026